Unfortunately, despite the ongoing saga of skin reactions towards diabetes medical devices, it has already been reported that the relatively new insulin pump system YpsoPump (Ypsomed, Burgdorf, Switzerland) also contains IBOA, and the first cases of ACD elicited by this device are known [41]. This evidence concerns the gene INS and diabetes mellitus.